Lakhashe, Samir K; Byrareddy, Siddappa N; Zhou, Mingkui; Bachler, Barbara C; Hemashettar, Girish; Hu, Shiu-Lok; et al.(2014). Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus. Vaccine, 32(48), 6527-6536. doi: 10.1016/j.vaccine.2014.08.065. UC Irvine: Institute for Clinical and Translational Science. Retrieved from: http://www.escholarship.org/uc/item/7f71h6qn
Sholukh, A. M., S. N. Byrareddy, V. Shanmuganathan, G. Hemashettar, S. K. Lakhashe, R. A. Rasmussen, J. D. Watkins, et al. 2014. “Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.” Retrovirology 11 (1): 8. doi:10.1186/1742-4690-11-8. http://dx.doi.org/10.1186/1742-4690-11-8.
Bachler, Barbara C, Michael Humbert, Samir K Lakhashe, Robert A Rasmussen, and Ruth M Ruprecht. 2013. “Live-virus exposure of vaccine-protected macaques alters the anti-HIV-1 antibody repertoire in the absence of viremia.” Retrovirology 10 (1): 63. doi:10.1186/1742-4690-10-63. http://dx.doi.org/10.1186/1742-4690-10-63.